Market Overview

IDEXX Labs Sees One-Time Reduction In Operating Profit of $16M To $20M

Related IDXX
Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares
Jim Cramer Shares His Thoughts On Xerox, Booking Holdings And More
  • Sees One-Time Reduction In Revenue Of $20M To $25M

Posted-In: News


Related Articles (IDXX)

View Comments and Join the Discussion!